2012
DOI: 10.1016/j.omega.2011.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of chemotherapy drugs: Planning policy for reduced waiting times

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 14 publications
0
23
0
Order By: Relevance
“…Vidal, Sahin, Martelli, Berhoune, and Bonan (2010) and Masselink, van der Mijden, Litvak, and Vanberkel (2012) both address the decision of which chemotherapy drugs to produce in advance, rather than on demand directly before use. These drugs are prepared for specific patients, and so become useless if patients are too ill for treatment and the drugs expire before they can be used.…”
Section: Other Treatment-related Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Vidal, Sahin, Martelli, Berhoune, and Bonan (2010) and Masselink, van der Mijden, Litvak, and Vanberkel (2012) both address the decision of which chemotherapy drugs to produce in advance, rather than on demand directly before use. These drugs are prepared for specific patients, and so become useless if patients are too ill for treatment and the drugs expire before they can be used.…”
Section: Other Treatment-related Studiesmentioning
confidence: 99%
“…Following the study, a decision support tool, designed to assist in choosing the drugs to produce in advance, was adopted by other pharmacies in France. Masselink et al (2012) worked with a pharmacy that is attached to a chemotherapy unit in the Netherlands. Unlike Vidal et al (2010), they focus on the effect on patient waiting times of preparing some chemotherapy drugs in advance.…”
Section: Other Treatment-related Studiesmentioning
confidence: 99%
“…The model relates the realised capacity to the expected access time (f a ) and expected number of idle slots (f e ) for each patient type. The discrete time queuing model is presented in analogy by the ones presented in Masselink, van der Mijden, Litvak, and Vanberkel (2012), Kortbeek et al (2014) and van de Vrugt, Boucherie, Smilde, de Jong, and Bessems (2017). The state of the model is the size of the backlog of a specific patient type p at the end of day d, B dp .…”
Section: The Stochastic Scheduling Problemmentioning
confidence: 99%
“…diagnostic imaging and pharmacy). In Masselink et al 2012) we investigate the impact of pharmacy policies on patient waiting time at the NCI. The study evaluated whether a reduction in waiting time resulting from medication orders being prepared in advance of patient appointments was justified, given that medications prepared in advance are wasted when patients arrive too sick for treatment.…”
Section: Designing and Managing Patient-centered Processes Of Carementioning
confidence: 99%